GLAXOSMITHKLINE CONSUMER HEALTHCARE INVESTMENTS (IRELAND) (NO.2) UNLIMITED COMPANY
DUNGARVAN


Company number FC031629
Status Active
Incorporation Date 31 October 2013
Company Type Other company type
Address KNOCKBRACK, DUNGARVAN, CO WATERFORD, IRELAND, IRELAND
Home Country IRELAND
Phone, email, etc

Since the company registration sixteen events have happened. The last three records are Termination of appointment of Adam Walker as a director on 1 August 2016; Termination of appointment of Alan George Burns as a director on 1 August 2016; Appointment of Jonathan Box as a director on 17 June 2016. The most likely internet sites of GLAXOSMITHKLINE CONSUMER HEALTHCARE INVESTMENTS (IRELAND) (NO.2) UNLIMITED COMPANY are www.glaxosmithklineconsumerhealthcareinvestmentsirelandno2unlimited.co.uk, and www.glaxosmithkline-consumer-healthcare-investments-ireland-no-2-unlimited.co.uk. The predicted number of employees is 1 to 10. The company’s age is twelve years and one months. Glaxosmithkline Consumer Healthcare Investments Ireland No 2 Unlimited Company is a Other company type. The company registration number is FC031629. Glaxosmithkline Consumer Healthcare Investments Ireland No 2 Unlimited Company has been working since 31 October 2013. The present status of the company is Active. The registered address of Glaxosmithkline Consumer Healthcare Investments Ireland No 2 Unlimited Company is Knockbrack Dungarvan Co Waterford Ireland Ireland. . EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED is a Secretary of the company. BOX, Jonathan Wilson is a Director of the company. FOSTER-HAWES, Melanie is a Director of the company. Director BLACKBURN, Paul Frederick has been resigned. Director BURNS, Alan George has been resigned. Director WALKER, Adam has been resigned.


Current Directors

Secretary
EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED
Appointed Date: 14 November 2013

Director
BOX, Jonathan Wilson
Appointed Date: 17 June 2016
62 years old

Director
FOSTER-HAWES, Melanie
Appointed Date: 17 June 2016
50 years old

Resigned Directors

Director
BLACKBURN, Paul Frederick
Resigned: 01 March 2016
Appointed Date: 14 November 2013
42 years old

Director
BURNS, Alan George
Resigned: 01 August 2016
Appointed Date: 14 November 2013
50 years old

Director
WALKER, Adam
Resigned: 01 August 2016
Appointed Date: 31 May 2015
58 years old

GLAXOSMITHKLINE CONSUMER HEALTHCARE INVESTMENTS (IRELAND) (NO.2) UNLIMITED COMPANY Events

19 Aug 2016
Termination of appointment of Adam Walker as a director on 1 August 2016
19 Aug 2016
Termination of appointment of Alan George Burns as a director on 1 August 2016
30 Jul 2016
Appointment of Jonathan Box as a director on 17 June 2016
30 Jul 2016
Appointment of Melanie Foster-Hawes as a director on 17 June 2016
08 Mar 2016
Termination of appointment of Paul Frederick Blackburn as a director on 1 March 2016
...
... and 6 more events
14 Nov 2013
Registration of a UK establishment of an overseas company
14 Nov 2013
Appointment at registration for BR016698 - person authorised to represent, Edinburgh Pharmaceutical Industries Limited 980 Great West Road Brentford Middlesex England, United Kingdomtw8 9Gs
14 Nov 2013
Appointment at registration for BR016698 - person authorised to represent, Burns Alan 980 Great West Road Brentford Middlesex England, United Kingdomtw8 9Gs
14 Nov 2013
Appointment at registration for BR016698 - person authorised to accept service, Edinburgh Pharmaceutical Industries Limited 980 Great West Road Brentford Middlesex Englandtw8 9Gs
14 Nov 2013
Appointment at registration for BR016698 - person authorised to represent, Blackburn Paul Frederick 980 Great West Road Brentford Middlesex England, United Kingdomtw8 9Gs